Table 1.
|
No incident hyperuricemia
|
Incident hyperuricemia
|
---|---|---|
Baseline risk factors | n = 7,908 | n = 304 |
Male sex |
37 |
49** |
Age, years |
53.8 (6) |
54.3 (5) |
African American race |
18 |
33** |
High school education or higher |
83 |
73** |
Pre-menopause
a,b
|
35 |
37 |
Smoking status
a
|
|
|
Current smoker |
22 |
27 |
Former smoker |
31 |
28 |
Never smoker |
47 |
45 |
Diuretic use |
12 |
19** |
Hypertension |
24 |
44** |
Total cholesterol, mmol/L |
6 (1) |
6 (1) |
HDL cholesterol
a
|
|
|
< 1.03 mmol/L |
20 |
26* |
1.03 ≤ HDL ≤ 1.55 |
48 |
50 |
> 1.55 |
32 |
24 |
Diabetes |
8 |
11* |
Coronary heart disease |
3 |
6* |
Congestive heart failure |
2 |
5* |
BMI, kg/m
2a
|
|
|
BMI ≥ 35 |
6 |
14** |
30 ≤ BMI < 35 |
15 |
23 |
25 ≤ BMI < 30 |
39 |
45 |
BMI < 25 |
40 |
18 |
Early adult obesity |
3 |
7** |
Weight change from early adult, lb |
25 (26) |
32 (30)** |
Waist-to-hip ratio, quartiles
a
|
|
|
Waist-to-hip ratio ≥ 0.97 |
23 |
38** |
0.92 ≤ Waist-to-hip ratio < 0.97 |
25 |
28 |
0.86 ≤ Waist -to-hip ratio < 0.92 |
26 |
22 |
0.86 ≤ Waist-to-hip ratio |
26 |
12 |
Categorical alcohol intake, grams/week
a
|
|
|
Abstain |
61 |
63* |
0–100 |
27 |
24 |
>100 |
12 |
13 |
Animal fat, grams/day |
35 (17) |
37 (18)* |
Animal protein, grams/day |
53 (23) |
53 (22) |
eGFR, ml/min/1.73 m
2a
|
|
|
<60 |
1 |
4** |
60–90 |
39 |
40 |
≥ 90 |
60 |
56 |
Baseline serum urate level, mg/dL |
5.3 (1.0) |
6.1 (0.78)** |
Serum urate level at 3 year follow-up, mg/dL |
5.5 (1.2) |
7.0 (1.3)** |
3-year change in serum urate level, mg/dL | 0.2 (0.9) | 0.9 (1.3)** |
Mean and standard deviation (SD) for continuous variables and percent for categorical variables.
*p-value < 0.05 ; **p-value < 0.001.
ap-value for trend.
bThe number of participants included in analysis was 4,551; men (n = 3,036) and women without known menopause status (n = 625) were excluded from this analysis.